Information:
Fel:
ID
16215
Beskrivning
A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00102219
Länk
https://clinicaltrials.gov/show/NCT00102219
Nyckelord
Versioner (1)
- 2016-07-05 2016-07-05 -
Uppladdad den
5 juli 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT00102219
Eligibility Breast Cancer NCT00102219
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00102219
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Locally advanced breast cancer | Carcinoma breast stage IV Amenable Local Therapy
Item
diagnosis of locally advanced or metastatic breast cancer that is not amenable to local treatment.
boolean
C3495949 (UMLS CUI [1])
C0278488 (UMLS CUI [2,1])
C3900053 (UMLS CUI [2,2])
C1517925 (UMLS CUI [2,3])
C0278488 (UMLS CUI [2,1])
C3900053 (UMLS CUI [2,2])
C1517925 (UMLS CUI [2,3])
Chemotherapy naive | Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant
Item
patients must be chemo-naive or have received only neoadjuvant and/or adjuvant chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0600558 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3])
C0919936 (UMLS CUI [1,2])
C0600558 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3])
Measurable lesion
Item
at least one measurable lesion.
boolean
C1513041 (UMLS CUI [1])
Chemotherapy
Item
no chemotherapy within 4 weeks prior to enrollment.
boolean
C0392920 (UMLS CUI [1])
Informed consent
Item
signed informed consent from the patient.
boolean
C0021430 (UMLS CUI [1])
Prior Chemotherapy Metastatic breast cancer
Item
prior chemotherapy for metastatic breast cancer.
boolean
C1514457 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,2])
Anthracyclines | Anthraquinones
Item
prior treatment with any anthracyclines or anthracenedione-containing regimen.
boolean
C0282564 (UMLS CUI [1])
C0003174 (UMLS CUI [2])
C0003174 (UMLS CUI [2])
Drugs, Non-Prescription
Item
treatment within the last 30 days with any drug that has not received regulatory approval.
boolean
C0013231 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy and/or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Unable to take Folic Acid | Unable to take Vitamin B12 supplement | Folic Acid Intake Unwilling | Vitamin B12 supplement Intake Unwilling
Item
inability or unwillingness to take folic acid or vitamin b12 supplementation.
boolean
C4074979 (UMLS CUI [1,1])
C0016410 (UMLS CUI [1,2])
C4074979 (UMLS CUI [2,1])
C3661610 (UMLS CUI [2,2])
C0016410 (UMLS CUI [3,1])
C1512806 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C3661610 (UMLS CUI [4,1])
C1512806 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])
C0016410 (UMLS CUI [1,2])
C4074979 (UMLS CUI [2,1])
C3661610 (UMLS CUI [2,2])
C0016410 (UMLS CUI [3,1])
C1512806 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C3661610 (UMLS CUI [4,1])
C1512806 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])